Sumitomo Pharma Co., Ltd. (TYO:4506)
680.00
-33.00 (-4.63%)
Apr 2, 2025, 3:30 PM JST
Sumitomo Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 283,268 | 158,122 | 321,807 | 479,930 | 765,586 | 557,406 | Upgrade
|
Market Cap Growth | 20.82% | -50.86% | -32.95% | -37.31% | 37.35% | -48.74% | Upgrade
|
Enterprise Value | 572,298 | 533,549 | 346,137 | 606,587 | 926,427 | 730,089 | Upgrade
|
Last Close Price | 713.00 | 398.00 | 810.00 | 1180.81 | 1850.26 | 1324.63 | Upgrade
|
PE Ratio | - | - | - | 8.51 | 13.62 | 13.68 | Upgrade
|
Forward PE | 18.74 | - | - | 11.10 | 19.40 | 14.75 | Upgrade
|
PS Ratio | 0.76 | 0.50 | 0.58 | 0.86 | 1.48 | 1.16 | Upgrade
|
PB Ratio | 1.71 | 1.01 | 0.79 | 0.71 | 1.18 | 0.88 | Upgrade
|
P/TBV Ratio | - | - | - | 34.15 | 37.03 | - | Upgrade
|
P/FCF Ratio | - | 92.74 | 20.09 | 5.91 | 14.51 | Upgrade
| |
P/OCF Ratio | - | 26.96 | 15.36 | 5.65 | 12.08 | Upgrade
| |
PEG Ratio | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 | Upgrade
|
EV/Sales Ratio | 1.54 | 1.70 | 0.62 | 1.08 | 1.80 | 1.51 | Upgrade
|
EV/EBITDA Ratio | - | - | 6.17 | 12.04 | 7.28 | Upgrade
| |
EV/EBIT Ratio | - | - | 10.12 | 17.06 | 8.81 | Upgrade
| |
EV/FCF Ratio | -35.61 | - | 99.75 | 25.39 | 7.15 | 19.01 | Upgrade
|
Debt / Equity Ratio | 2.25 | 2.74 | 0.85 | 0.42 | 0.45 | 0.50 | Upgrade
|
Debt / EBITDA Ratio | - | - | - | 2.89 | 3.78 | 3.14 | Upgrade
|
Debt / FCF Ratio | - | - | 99.82 | 11.91 | 2.24 | 8.21 | Upgrade
|
Asset Turnover | 0.39 | 0.31 | 0.46 | 0.43 | 0.40 | 0.46 | Upgrade
|
Inventory Turnover | 1.39 | 1.21 | 1.85 | 1.64 | 1.61 | 1.77 | Upgrade
|
Quick Ratio | 0.37 | 0.25 | 0.65 | 1.27 | 1.19 | 0.49 | Upgrade
|
Current Ratio | 0.67 | 0.52 | 1.03 | 1.79 | 1.65 | 0.73 | Upgrade
|
Return on Equity (ROE) | -69.06% | -111.89% | -17.90% | 6.14% | 5.75% | 6.36% | Upgrade
|
Return on Assets (ROA) | -14.65% | -21.74% | -6.46% | 2.86% | 2.65% | 4.96% | Upgrade
|
Return on Capital (ROIC) | -21.62% | -33.20% | -9.23% | 3.95% | 3.60% | 7.01% | Upgrade
|
Return on Capital Employed (ROCE) | - | - | - | 5.80% | 5.30% | 11.00% | Upgrade
|
Earnings Yield | -62.15% | -199.19% | -23.15% | 11.75% | 7.34% | 7.31% | Upgrade
|
FCF Yield | -5.67% | -159.79% | 1.08% | 4.98% | 16.92% | 6.89% | Upgrade
|
Dividend Yield | 0.00% | - | 2.59% | 2.37% | 1.51% | 2.11% | Upgrade
|
Payout Ratio | 0.00% | - | - | 19.72% | 19.78% | 32.16% | Upgrade
|
Buyback Yield / Dilution | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
| |
Total Shareholder Return | - | 2.59% | 2.37% | 1.51% | 2.11% | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.